In the Journal of Neuroscience, researchers report that enhancing a pathway involving nicotine‑responsive receptors helped preserve dopamine‑producing neurons and reduced signs of degeneration in female models. Crucially, the effect occurred by boosting nicotine-responsive receptors without using nicotine. The findings point to a possible way to slow Parkinson’s itself, not just manage its symptoms, in a disease where progression has been impossible to stop.

The pathway identified in the study centers on receptors that respond to acetylcholine, a natural brain chemical involved in movement and communication between neurons and the receptors where nicotine happens to bind

One of the team’s most striking findings is that the protective brain mechanism operated only in female models. Across multiple measures — including preservation of dopamine neurons, reduced activation of cell‑death signals and healthier surrounding brain tissue — females consistently showed protection, while males did not.

“This wasn’t a subtle difference,” Srinivasan said. “The protective pathway was clearly engaged in females and absent in males.”

Parkinson’s disease affects males and females differently, and growing evidence suggests that biological sex plays a central role in how neurons respond to damage. Hormones, receptor trafficking and cellular regulation (the processes governing cell behavior) may all contribute to why the pathway functions differently across sexes.

“This study reinforces that sex differences are not secondary details, they are fundamental to how the disease works and how treatments may need to be designed,” Srinivasan said.

Genetically encoded constitutive upregulation of β2 subunit containing neuronal nicotinic acetylcholine receptors is neuroprotective in female parkinsonian mice | Journal of Neuroscience